Rush MD Anderson Cancer Center at Rush Oak Park — Oak Park, Illinois

Rush MD Anderson Cancer Center at Rush Oak Park is a clinical research site located in Oak Park, Illinois, United States 60304.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rush MD Anderson Cancer Center at Rush Oak Park has participated in 12 clinical trials with 12 currently active.

Therapeutic areas: Ovarian Carcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma.

Sponsors: NRG Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush MD Anderson Cancer Center at Rush Oak Park?

Rush MD Anderson Cancer Center at Rush Oak Park has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush MD Anderson Cancer Center at Rush Oak Park conducted?

Rush MD Anderson Cancer Center at Rush Oak Park has 12 clinical trials on record, with 12 currently active. Their work covers Ovarian Carcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma.

Is Rush MD Anderson Cancer Center at Rush Oak Park accredited by Crixeo Health?

Yes — Rush MD Anderson Cancer Center at Rush Oak Park holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rush MD Anderson Cancer Center at Rush Oak Park?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.